Mucus Clearance Devices Market by Cycle Type (HFCWO Devices, OPEP Devices, MCA Devices, IPV Devices, PEP Devices), Indication (Cystic Fibrosis, COPD, Bronchiectasis, Others), End User & Region - Forecast to 2018-2028

Top 3 Factors Impacting the Growth of the Mucus Clearance Devices Market

1. Growing Popularity of PEP & OPEP Devices

   Mucus clearance devices are considered medically necessary for the treatment of COPD, cystic fibrosis, bronchiectasis, and asthma. Increase in the number of requests about traveling with PEP machines internationally is boosting the global mucus clearance devices market. PEP is the standard therapy that is required, and it offers substantial health benefits when it is used as prescribed.

   Moreover, the launch of few mucus clearance devices, such as Aerobika, The Lung Flute, Flutter, Acapella, and others, has propelled the mucus clearance devices market. This has ultimately increased the popularity of PEP and OPEP devices, which is another factor that is expected to drive the revenue growth of the mucus clearance devices market over the forecast period

2. Increasing Focus of Companies Towards Homecare Settings

   The providers of mucus clearance devices are primarily focusing on providing full service, which is likely to provide comprehensive information about a variety of respiratory disorders. Companies are more focused on maintaining a patient-centric culture. New products foster patient engagement with PEP, OPEP, and HFCWO therapy, which helps improve adherence to the prescribed treatment and better patient outcomes in homecare settings and clinics.

   The increasing usage of mucus clearance devices in home settings, technological assessments, changing healthcare guidelines, and the requirements of insurance payers are among the factors expected to significantly change the role of physicians, payers, and patients. Therefore, the increasing adoption of mucus clearance devices in homecare settings is expected to propel the mucus clearance devices market over the forecast period.

3. Rising Patient Pool Suffering from COPD

   The Journal of Thoracic Disease reveals that approximately 3-4% of the population of China is suffering from COPD owing to high exposure to biomass smoke. A Study by WHO highlights that approximately 65 Mn people around the globe are suffering from COPD. The same study also estimates that this prevalence is expected to double by 2050. Furthermore, this study explains that high-income countries have greater prevalence owing to rising pollution. This factor is projected to drive the mucus clearance devices market.

Mucus Clearance Devices Market: Competitive Analysis

• The global mucus clearance devices market is highly consolidated, and the top five-six players are estimated to account for a market share of approximately 85%
• Hill-Rom Inc. accounted for a share of 35.3% of the global market in 2017 due to its focus on expansion in the emerging economies
• Allergan, Philips, Respiratory Technologies, Smiths Medical, and Electromed Inc. collectively accounted for a 49.3% share of the global mucus clearance devices market owing to the focus of these companies on key countries such as Brazil, India, Russia, China, and Mexico
• Other regional and local players, such as Westmed, Inc., International Biophysics Corp., Thayer Medical, and VORTRAN Medical, are estimated to gain the remaining revenue share of the mucus clearance devices market in 2017

Mucus Clearance Devices – Focus on Homecare Settings

Inclination of the healthcare sector’s focus on a more patient-centric approach as health issues continue to become a major concern, and more entrepreneurs leverage the prevalence with innovating offerings that improve health outcomes. This will significantly rub off on demand for airway clearance products and mucus clearance devices, as the prevalence of chronic lung diseases continues to rise and shows no signs of abating.

Market Set to Grow 1.8X between 2018 and 2028

The palpable rise in mobile applications connected with respiratory devices, including the smart vest systems, continue to empower care providers, while telemedicine services apropos of mucus clearance have been gaining a notable traction. These aspects continue to propel development and adoption of mucus clearance devices.

Emerging Markets – Second Wave of Growth

Mucus clearance device sales show a remarkable rate in South Asia, East Asia, and Latin America, upheld by several macro trends that range from government focus on increasing the reimbursement support and customer care services, to sales force expansion efforts of the regional manufacturers and care providers.

The Broader Perspective

Stakeholders are shifting their production facilities to emerging economies in light of their ease access to resources and more lucrative market positioning of products, considering the latent growth potency of these nations.

Influence of Combination Therapies on Market Prospects

Prospects remain bullish for the mucus clearance devices landscape, attributed in part to the potential scope of combination therapies. Greater reliability and convenient reimbursement policies, along with the requirement for multiple devices in most high-risk patients, collectively allude high growth in adoption of combination therapies in the marketplace.

Global Mucus Clearance Device Market: Segmentation:

The global mucus clearance devices is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader.

By Cycle Type

• HFCWO Devices
• OPEP Devices
• MCA Devices
• IPV Devices
• PEP Devices 

By Indication

• Cystic Fibrosis
• COPD
• Bronchiectasis
• Others

By End User

• Direct / Patient
• Hospitals
• Fertility Clinics & IVF Centres

By Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa